ABBV
AbbVie Inc.
- Free cash flow, 2025
- $17.8B
- YoY, 2025
- −0.1%
- 5-year CAGR
- +1.2%
- 10-year CAGR
- +9.8%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $17.8B | −0.1% |
| 2024 | $17.8B | −19.2% |
| 2023 | $22.1B | −9.0% |
| 2022 | $24.2B | +10.3% |
| 2021 | $22.0B | +31.0% |
| 2020 | $16.8B | +31.5% |
| 2019 | $12.8B | −0.1% |
| 2018 | $12.8B | +35.6% |
| 2017 | $9.4B | +43.7% |
| 2016 | $6.6B | −6.3% |
| 2015 | $7.0B | +138.4% |
| 2014 | $2.9B | −49.2% |
| 2013 | $5.8B | −3.9% |
| 2012 | $6.0B | +2.1% |
| 2011 | $5.9B | — |